Pierre Lucien Schoenheimer

All filings by Pierre Lucien Schoenheimer on record concern Artemis Therapeutics, Inc. Over a trading history stretching from 30 March 2007 to 3 March 2011, the count stands at 6 filings.

Both buying and selling appear: 2 purchases worth €218k, against 3 sales worth €8,034. Netting one side against the other leaves €210k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant. So far in 2011, the count stands at no purchases and 1 sale.

The latest filing, published on 8 March 2011, reports an open-market sale of €1,298 in Artemis Therapeutics, Inc. The most recent open-market purchase was published on 19 March 2010, 6,063 days ago. Typically, a trade is published a median of 5 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.